Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Xeroderma pigmentosum C is involved in Epstein Barr virus DNA replication.

Lu CC, Chen YC, Wang JT, Yang PW, Chen MR.

J Gen Virol. 2007 Dec;88(Pt 12):3234-43.

PMID:
18024891
2.

Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase.

Murata T, Isomura H, Yamashita Y, Toyama S, Sato Y, Nakayama S, Kudoh A, Iwahori S, Kanda T, Tsurumi T.

Virology. 2009 Jun 20;389(1-2):75-81. doi: 10.1016/j.virol.2009.04.007. Epub 2009 May 8.

3.

Characterization of Epstein-Barr virus BGLF4 kinase expression control at the transcriptional and translational levels.

Wang JT, Chuang YC, Chen KL, Lu CC, Doong SL, Cheng HH, Chen YL, Liu TY, Chang Y, Han CH, Yeh SW, Chen MR.

J Gen Virol. 2010 Sep;91(Pt 9):2186-96. doi: 10.1099/vir.0.019729-0. Epub 2010 May 5.

PMID:
20444992
4.

Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II.

Lee CP, Chen JY, Wang JT, Kimura K, Takemoto A, Lu CC, Chen MR.

J Virol. 2007 May;81(10):5166-80. Epub 2007 Mar 14.

5.

Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase.

Yang PW, Chang SS, Tsai CH, Chao YH, Chen MR.

J Gen Virol. 2008 Apr;89(Pt 4):884-95. doi: 10.1099/vir.0.83546-0.

PMID:
18343828
6.

Latent and lytic Epstein-Barr virus replication strategies.

Tsurumi T, Fujita M, Kudoh A.

Rev Med Virol. 2005 Jan-Feb;15(1):3-15. Review.

PMID:
15386591
7.
8.

Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins.

Chang CW, Lee CP, Huang YH, Yang PW, Wang JT, Chen MR.

J Virol. 2012 Aug;86(15):8072-85. doi: 10.1128/JVI.01058-12. Epub 2012 May 23.

9.

Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production.

Lee CP, Huang YH, Lin SF, Chang Y, Chang YH, Takada K, Chen MR.

J Virol. 2008 Dec;82(23):11913-26. doi: 10.1128/JVI.01100-08. Epub 2008 Sep 24.

10.

BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteins.

Chang CW, Lee CP, Su MT, Tsai CH, Chen MR.

J Virol. 2015 Feb;89(3):1703-18. doi: 10.1128/JVI.02880-14. Epub 2014 Nov 19.

11.

Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles.

Wang JT, Yang PW, Lee CP, Han CH, Tsai CH, Chen MR.

J Gen Virol. 2005 Dec;86(Pt 12):3215-25.

PMID:
16298966
12.

DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.

Wang'ondu R, Teal S, Park R, Heston L, Delecluse H, Miller G.

PLoS One. 2015 May 7;10(5):e0126088. doi: 10.1371/journal.pone.0126088. eCollection 2015.

13.

Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex.

Su MT, Liu IH, Wu CW, Chang SM, Tsai CH, Yang PW, Chuang YC, Lee CP, Chen MR.

J Virol. 2014 Aug;88(16):8883-99. doi: 10.1128/JVI.00950-14. Epub 2014 May 28.

14.

Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway.

Wang JT, Doong SL, Teng SC, Lee CP, Tsai CH, Chen MR.

J Virol. 2009 Feb;83(4):1856-69. doi: 10.1128/JVI.01099-08. Epub 2008 Dec 3.

15.

HHR23A, a human homolog of Saccharomyces cerevisiae Rad23, regulates xeroderma pigmentosum C protein and is required for nucleotide excision repair.

Hsieh HC, Hsieh YH, Huang YH, Shen FC, Tsai HN, Tsai JH, Lai YT, Wang YT, Chuang WJ, Huang W.

Biochem Biophys Res Commun. 2005 Sep 16;335(1):181-7.

PMID:
16105547
16.

Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication.

Kudoh A, Daikoku T, Ishimi Y, Kawaguchi Y, Shirata N, Iwahori S, Isomura H, Tsurumi T.

J Virol. 2006 Oct;80(20):10064-72.

17.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
18.

A molecular link between malaria and Epstein-Barr virus reactivation.

ChĂȘne A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT.

PLoS Pathog. 2007 Jun;3(6):e80.

19.

Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4.

Zhu J, Liao G, Shan L, Zhang J, Chen MR, Hayward GS, Hayward SD, Desai P, Zhu H.

J Virol. 2009 May;83(10):5219-31. doi: 10.1128/JVI.02378-08. Epub 2009 Feb 25.

20.

SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.

Li R, Wang L, Liao G, Guzzo CM, Matunis MJ, Zhu H, Hayward SD.

J Virol. 2012 May;86(10):5412-21. doi: 10.1128/JVI.00314-12. Epub 2012 Mar 7.

Supplemental Content

Support Center